Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is a promising treatment for alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Higher antigliadin antibody levels are linked to alopecia areata severity.

The document covers various dermatological conditions and their studies.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Combining microneedling with triamcinolone acetonide is more effective for treating alopecia areata than microneedling alone.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Certain factors like patchy hair loss at the back of the head, being female, and younger age at diagnosis can lead to a worse outcome for alopecia areata.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Enhancing Tregs can protect against alopecia areata.

Certain gene variations increase the risk of alopecia areata in Koreans.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Alopecia Areata patients experience higher social appearance anxiety due to visible hair loss.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Patients with Alopecia Areata are willing to trade life duration for better quality of life.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.